Particularly noteworthy, the increase in interaction pairs involving IFNG_(IFNGR1+IFNGR2) in OT samples, indicating that the combination therapy enhances the secretion of interferon by CD8+ T cells, which in turn interact with malignant cells to execute anti‐tumour effect.67 This evidence concerns the gene CD8A and neoplasm.